Biote (NASDAQ:BTMD) reported quarterly losses of $(0.23) per share which missed the analyst consensus estimate of $0.04 by 675 percent. This is a 330 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $44.232 million which missed the analyst consensus estimate of $46.148 million by 4.15 percent. This is a 9.55 percent decrease over sales of $48.900 million the same period last year.